Ibaraki Prefectural Central Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis1 trial
• Chronic rhinosinusitis with nasal polyps1 trial
• Cystic fibrosis1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• CSL Behring1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

  NCT07048262· Phase 2· CSL Behring· Source

  Contact: Trial Registration Coordinator

• Recruiting

  A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

  NCT06338995· Phase 3· Eli Lilly and Company· Source

  Contact: Bungo Nishimura (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis1 recruiting
• Chronic rhinosinusitis with nasal polyps1 recruiting
• Cystic fibrosis1 recruiting